Personal information

Websites & social links

Google Scholar
Publons
Twitter

Other IDs

Scopus Author ID: 7202292457
Loop profile: 619147

Activities

Collapse all

Employment (4)

University of Queensland: Brisbane, AU

2025-01-01 to present | Associate Professor/Group Leader/Principal Research Fellow (Frazer Institute)
Employment
Source: Self-asserted source
Mitchell Stark

University of Queensland: Brisbane, Queensland, AU

2020-12-01 to 2024-12-31 | Group Leader/Senior Research Fellow (Frazer Institute)
Employment
Source: Self-asserted source
Mitchell Stark

University of Queensland: Brisbane, AU

2015-07-31 to 2020-12-01 | Research Fellow (The University of Queensland Diamantina Institute)
Employment
Source: Self-asserted source
Mitchell Stark

QIMR Berghofer Medical Research Institute: Herston, QLD, AU

1999 to 2015-06 | Senior Research Assistant
Employment
Source: Self-asserted source
Mitchell Stark

Works (50 of 92)

Items per page:
Page 1 of 2

Mitochondrial Deletion4977 Abundance in Melanoma-Adjacent Skin

Journal of Investigative Dermatology
2024-12 | Journal article
DOI: 10.1016/j.jid.2024.11.009
Contributors: Katie J. Lee; Yung-Ching Kao; Darren J. Smit; Brigid Betz-Stablein; Nancy Huang; Sam Kahler; H. Peter Soyer; Mitchell S. Stark
Source: check_circle
Crossref

Uncovering the molecular mechanisms of amelanotic/hypopigmented primary cutaneous melanoma

British Journal of Dermatology
2024-12-23 | Journal article
DOI: 10.1093/bjd/ljae336
Contributors: Richard A Sturm; Darren J Smit; David L Duffy; Catriona McLean; Richard A Scolyer; Grant A McArthur; Anthony T Papenfuss; Mitchell S Stark; H Peter Soyer; Victoria J Mar
Source: check_circle
Crossref

Challenging the Lymph Node Progression Model of Melanoma

Journal of Investigative Dermatology
2024-11 | Journal article
DOI: 10.1016/j.jid.2024.04.021
Contributors: Yung-Ching Kao; Mitchell S. Stark
Source: check_circle
Crossref

MicroRNA Expression Profiling of Cutaneous Squamous Cell Carcinomas and Precursor Lesions

Skin Health and Disease
2024-06-01 | Journal article
DOI: 10.1002/ski2.360
Contributors: Akbor Hossain; Lisa N. Tom; Ala Melati-Rad; Miko Yamada; Sabrina Hammerlindl; Kasturee Jagirdar; Tarl W. Prow; H. Peter Soyer; Mitchell S. Stark
Source: check_circle
Crossref

The Skin Molecular Ecosystem Holds the Key to Nevogenesis and Melanomagenesis

Journal of Investigative Dermatology
2024-03 | Journal article
DOI: 10.1016/j.jid.2023.09.271
Contributors: Katie J. Lee; H. Peter Soyer; Mitchell S. Stark
Source: check_circle
Crossref

Terahertz in vivo imaging of human skin: Toward detection of abnormal skin pathologies

APL Bioengineering
2024-03-01 | Journal article
DOI: 10.1063/5.0190573
Contributors: X. Qi; K. Bertling; J. Torniainen; F. Kong; T. Gillespie; C. Primiero; M. S. Stark; P. Dean; D. Indjin; L. H. Li et al.
Source: check_circle
Crossref

Assessing the genetic risk of nodular melanoma using a candidate gene approach

British Journal of Dermatology
2024-01-23 | Journal article
DOI: 10.1093/bjd/ljad365
Contributors: Mitchell S Stark; Richard A Sturm; Yan Pan; Darren J Smit; Varsha Kommajosyula; Katie J Lee; Kasturee Jagirdar; Catriona McLean; David L Duffy; H Peter Soyer et al.
Source: check_circle
Crossref

BRAF variant allele fraction—A predictor of response to targeted therapy?

Journal of the European Academy of Dermatology and Venereology
2023-10 | Journal article
DOI: 10.1111/jdv.19389
Contributors: Mitchell S. Stark; Teresa Harris; Douglas Grossman; Robert Judson‐Torres
Source: check_circle
Crossref

Distinct HOX Gene Family DNA Methylation Profiles in Histologically Normal Skin Dependent on Dermoscopic Pattern of Adjacent Nevi

Journal of Investigative Dermatology
2023-09 | Journal article
DOI: 10.1016/j.jid.2023.03.1653
Contributors: Meghan E. Muse; Helmut Schaider; Harald Oey; H. Peter Soyer; Brock C. Christensen; Mitchell S. Stark
Source: check_circle
Crossref

GOLM1: expanding our understanding of melanoma susceptibility

Journal of Medical Genetics
2023-09 | Journal article
DOI: 10.1136/jmg-2023-109348
Contributors: Ellie J. Maas; Courtney K. Wallingford; Emily DeBortoli; Darren J Smit; Brigid Betz-Stablein; Lauren G Aoude; Mitchell S Stark; Richard A. Sturm; H. Peter Soyer; Aideen M McInerney-Leo
Source: check_circle
Crossref

One step closer to improving melanoma diagnosis and prognosis with liquid biopsies

British Journal of Dermatology
2023-08-24 | Journal article
DOI: 10.1093/bjd/ljad185
Contributors: Ismael A Vergara; Mitchell S Stark
Source: check_circle
Crossref

Spatial Randomness in the Distribution of Acquired Melanocytic Nevi of the Back in a Population-Based Sample

Journal of Investigative Dermatology
2023-06 | Journal article
DOI: 10.1016/j.jid.2022.11.013
Contributors: Dilki Jayasinghe; Brigid Betz-Stablein; Mitchell S. Stark; H. Peter Soyer; Monika Janda
Source: check_circle
Crossref

Terahertz imaging of human skin pathologies using laser feedback interferometry with quantum cascade lasers

Biomedical Optics Express
2023-04-01 | Journal article
DOI: 10.1364/boe.480615
Part of ISSN: 2156-7085
Part of ISSN: 2156-7085
Contributors: Xiaoqiong Qi; Karl Bertling; Mitchell S. Stark; Thomas Taimre; Yung-Ching Kao; Yah Leng Lim; She Han; Blake O’Brien; Angus Collins; Michael Walsh et al.
Source: Self-asserted source
Mitchell Stark

Deficiencies in mismatch DNA repair: providing the soil for large-to-giant congenital melanocytic naevus development

British Journal of Dermatology
2023-01-23 | Journal article
DOI: 10.1093/bjd/ljac037
Contributors: Mitchell S Stark
Source: check_circle
Crossref

In Vivo Melanoma Cell Morphology and Tumor Aggressiveness: The Promise of Reflectance Confocal Microscopy in Reducing Unnecessary Excisions

Journal of Investigative Dermatology
2022-08 | Journal article
DOI: 10.1016/j.jid.2022.01.011
Contributors: Katie J. Lee; Mitchell S. Stark
Source: check_circle
Crossref

Current Trends in Circulating Biomarkers for Melanoma Detection

Frontiers in Medicine
2022-04-05 | Journal article
DOI: 10.3389/fmed.2022.873728
Part of ISSN: 2296-858X
Source: Self-asserted source
Mitchell Stark

An Integrated Microfluidic‐SERS Platform Enables Sensitive Phenotyping of Serum Extracellular Vesicles in Early Stage Melanomas

Advanced Functional Materials
2022-01 | Journal article
DOI: 10.1002/adfm.202010296
Contributors: Jing Wang; Yung‐Ching Kao; Quan Zhou; Alain Wuethrich; Mitchell S. Stark; Helmut Schaider; H. Peter Soyer; Lynlee L. Lin; Matt Trau
Source: check_circle
Crossref

The Future of Precision Prevention for Advanced Melanoma

Frontiers in Medicine
2022-01-17 | Journal article
DOI: 10.3389/fmed.2021.818096
Part of ISSN: 2296-858X
Source: Self-asserted source
Mitchell Stark

Genome-scale DNA methylation analysis identifies repeat element alterations that modulate the genomic stability of melanocytic nevi

Journal of Investigative Dermatology
2021-12 | Journal article
DOI: 10.1016/j.jid.2021.11.025
Part of ISSN: 0022-202X
Source: Self-asserted source
Mitchell Stark

Genetic analysis of multiple primary melanomas arising within the boundaries of congenital nevi depigmentosa

Pigment Cell & Melanoma Research
2021-11 | Journal article
DOI: 10.1111/pcmr.12979
Contributors: Allison M. Fuiten; Reilly G. Fankhauser; Darren J. Smit; Mitchell S. Stark; Trevor F. Enright; Mary A. Wood; Nicholas A. DePatie; Karla Pivik; Richard A. Sturm; Elizabeth G. Berry et al.
Source: check_circle
Crossref

MicroRNA expression is associated with human papillomavirus status and prognosis in mucosal head and neck squamous cell carcinomas

Oral Oncology
2021-02 | Journal article
DOI: 10.1016/j.oraloncology.2020.105136
Part of ISSN: 1368-8375
Source: Self-asserted source
Mitchell Stark

On Naevi and Melanomas: Two Sides of the Same Coin?

Frontiers in medicine
2021-02-19 | Journal article
DOI: 10.3389/fmed.2021.635316
PMID: 33681261
PMC: PMC7933521
Source: Self-asserted source
Mitchell Stark

Mutation Signatures in Melanocytic Nevi Reveal Characteristics of Defective DNA Repair

Journal of Investigative Dermatology
2020-10 | Journal article
DOI: 10.1016/j.jid.2020.02.021
Contributors: Mitchell S. Stark; Evgeniya Denisova; Trent A. Kays; Barbara Heidenreich; Sivaramakrishna Rachakonda; Celia Requena; Richard A. Sturm; H. Peter Soyer; Eduardo Nagore; Rajiv Kumar
Source: check_circle
Crossref

Germline and somatic albinism variants in amelanotic/hypomelanotic melanoma: Increased carriage of TYR and OCA2 variants

PLOS ONE
2020-09-23 | Journal article
DOI: 10.1371/journal.pone.0238529
Part of ISSN: 1932-6203
Source: Self-asserted source
Mitchell Stark

The distinctive genomic landscape of giant congenital melanocytic nevi

Journal of Investigative Dermatology
2020-08 | Journal article
DOI: 10.1016/j.jid.2020.07.022
Part of ISSN: 0022-202X
Source: Self-asserted source
Mitchell Stark
grade
Preferred source (of 2)‎

Prognostic Gene Expression Profiling in Cutaneous Melanoma

JAMA Dermatology
2020-07-29 | Journal article
DOI: 10.1001/jamadermatol.2020.1729
Part of ISSN: 2168-6068
Source: Self-asserted source
Mitchell Stark

Regional Variation in Epidermal Susceptibility to UV-Induced Carcinogenesis Reflects Proliferative Activity of Epidermal Progenitors

Cell Reports
2020-06 | Journal article
DOI: 10.1016/j.celrep.2020.107702
Part of ISSN: 2211-1247
Source: Self-asserted source
Mitchell Stark

CDKN2A testing threshold in a high‐risk Australian melanoma cohort: number of primaries, family history and young age of onset impact risk

Journal of the European Academy of Dermatology and Venereology
2020-05-09 | Journal article
DOI: 10.1111/jdv.16627
Part of ISSN: 0926-9959
Part of ISSN: 1468-3083
Source: Self-asserted source
Mitchell Stark

Defining the Molecular Genetics of Dermoscopic Naevus Patterns

Dermatology
2019 | Journal article
DOI: 10.1159/000493892
Contributors: Jean-Marie Tan; Lisa N. Tom; H. Peter Soyer; Mitchell S. Stark
Source: check_circle
Crossref
grade
Preferred source (of 3)‎

High naevus count and MC1R red hair alleles contribute synergistically to increased melanoma risk

Br J Dermatol
2019 | Journal article
DOI: 10.1111/bjd.17833
Contributors: Duffy, D. L.; Lee, K. J.; Jagirdar, K.; Pflugfelder, A.; Stark, M. S.; McMeniman, E. K.; Soyer, H. P.; Sturm, R. A.
Source: Self-asserted source
Mitchell Stark via ResearcherID
grade
Preferred source (of 2)‎

Multiple interaction nodes define the post‐replication repair response to UV‐induced DNA damage that is defective in melanomas and correlated with UV signature mutation load

Molecular Oncology
2019-11-16 | Journal article
DOI: 10.1002/1878-0261.12601
Part of ISSN: 1574-7891
Part of ISSN: 1878-0261
Source: Self-asserted source
Mitchell Stark
grade
Preferred source (of 2)‎

A Panel of Circulating MicroRNAs Detects Uveal Melanoma With High Precision

Translational Vision Science & Technology
2019-11-14 | Journal article
DOI: 10.1167/tvst.8.6.12
Part of ISSN: 2164-2591
Source: Self-asserted source
Mitchell Stark

Large-Giant Congenital Melanocytic Nevi: Moving Beyond NRAS Mutations.

The Journal of investigative dermatology
2019-04-01 | Journal article
DOI: 10.1016/j.jid.2018.10.003
PMID: 30904080
Source: Self-asserted source
Mitchell Stark

Distinct histone modifications denote early stress-induced drug tolerance in cancer

Oncotarget
2018 | Journal article
DOI: https://doi.org/10.18632/oncotarget.23654
Contributors: Emran , Abdullah Al; Marzese, Diego M; Menon, Dinoop Ravindran; Stark, Mitchell S; Torrano, Joachim; Hammerlindl, Heinz; Zhang, Gao; Brafford, Patricia; Salomon, Matthew P; Nelson, Nellie et al.
Source: Self-asserted source
Mitchell Stark via ResearcherID
grade
Preferred source (of 2)‎

Somatic inactivating PTPRJ mutations and dysregulated pathways identified in canine malignant melanoma by integrated comparative genomic analysis

PLoS Genet
2018 | Journal article
DOI: 10.1371/journal.pgen.1007589
Contributors: Hendricks, W. P. D.; Zismann, V.; Sivaprakasam, K.; Legendre, C.; Poorman, K.; Tembe, W.; Perdigones, N.; Kiefer, J.; Liang, W.; DeLuca, V. et al.
Source: Self-asserted source
Mitchell Stark via ResearcherID
grade
Preferred source (of 2)‎

The BRAF and NRAS mutation prevalence in dermoscopic subtypes of acquired naevi reveals constitutive mitogen-activated protein kinase pathway activation

Br J Dermatol
2018 | Journal article
DOI: 10.1111/bjd.15809
Contributors: Tan, J. M.; Tom, L. N.; Jagirdar, K.; Lambie, D.; Schaider, H.; Sturm, R. A.; Soyer, H. P.; Stark, M. S.
Source: Self-asserted source
Mitchell Stark via ResearcherID
grade
Preferred source (of 3)‎

Whole-exome sequencing of acquired nevi identifies mechanisms for development and maintenance of benign neoplasms

J Invest Dermatol
2018 | Journal article
DOI: 10.1016/j.jid.2018.02.012
Contributors: Stark, M. S.; Tan, J. M.; Tom, L.; Jagirdar, K.; Lambie, D.; Schaider, H.; Soyer, H. P.; Sturm, R. A.
Source: Self-asserted source
Mitchell Stark via ResearcherID
grade
Preferred source (of 3)‎

Treatment And Detection Of Melanoma

2018-02-28 | Patent
LENSID: 082-535-186-422-119
URI:

lens.org/082-535-186-422-119

PAT:

EP 3186394 A4
Source: Self-asserted source
Mitchell Stark via The Lens

Gene Expression Array Analysis to Identify Candidate Tumor Suppressor Genes in Melanoma

Methods Mol Biol
2017 | Book chapter
DOI: 10.1007/7651_2017_54
Source: Self-asserted source
Mitchell Stark
grade
Preferred source (of 2)‎

Melanoma treatment guided by a panel of microRNA biomarkers

Melanoma Management
2017 | Journal article
DOI: 10.2217/mmt-2017-0006
Contributors: Stark, Mitchell S
Source: Self-asserted source
Mitchell Stark via ResearcherID

The 'Melanoma-enriched' microRNA miR-4731-5p acts as a tumour suppressor

Oncotarget
2016 | Journal article
DOI: 10.18632/oncotarget.10109
Contributors: Stark, M. S.; Tom, L. N.; Boyle, G. M.; Bonazzi, V. F.; Soyer, H. P.; Herington, A. C.; Pollock, P. M.; Hayward, N. K.
Source: Self-asserted source
Mitchell Stark via ResearcherID
grade
Preferred source (of 2)‎

MicroRNA and mRNA expression profiling in metastatic melanoma reveal associations with BRAF mutation and patient prognosis

Pigment Cell Melanoma Res
2015 | Journal article
DOI: 10.1111/pcmr.12343
Contributors: Tembe, V.; Schramm, S. J.; Stark, M. S.; Patrick, E.; Jayaswal, V.; Tang, Y. H.; Barbour, A.; Hayward, N. K.; Thompson, J. F.; Scolyer, R. A. et al.
Source: Self-asserted source
Mitchell Stark via ResearcherID
grade
Preferred source (of 2)‎

miR-514a regulates the tumour suppressor NF1 and modulates BRAFi sensitivity in melanoma

Oncotarget
2015 | Journal article
DOI: 10.18632/oncotarget.3924
EID:

2-s2.0-84938264915
Contributors: Stark, M.S.; Bonazzi, V.F.; Boyle, G.M.; Palmer, J.M.; Symmons, J.; Lanagan, C.M.; Schmidt, C.W.; Herington, A.C.; Ballotti, R.; Pollock, P.M. et al.
Source: Self-asserted source
Mitchell Stark via Scopus - Elsevier

Nonsense Mutations in the Shelterin Complex Genes ACD and TERF2IP in Familial Melanoma.

Journal of the National Cancer Institute
2015 | Journal article
DOI: 10.1093/jnci/dju408
WOSUID:

MEDLINE:25505254
Contributors: Aoude, Lauren G; Pritchard, Antonia L; Robles-Espinoza, Carla Daniela; Wadt, Karin; Harland, Mark; Choi, Jiyeon; Gartside, Michael; Quesada, Victor; Johansson, Peter; Palmer, Jane M et al.
Source: Self-asserted source
Mitchell Stark via ResearcherID
grade
Preferred source (of 2)‎

The Prognostic and Predictive Value of Melanoma-related MicroRNAs Using Tissue and Serum: A MicroRNA Expression Analysis

EBioMedicine
2015 | Journal article
DOI: 10.1016/j.ebiom.2015.05.011
Contributors: Stark, M. S.; Klein, K.; Weide, B.; Haydu, L. E.; Pflugfelder, A.; Tang, Y. H.; Palmer, J. M.; Whiteman, D. C.; Scolyer, R. A.; Mann, G. J. et al.
Source: Self-asserted source
Mitchell Stark via ResearcherID
grade
Preferred source (of 2)‎

Defective Decatenation Checkpoint Function Is a Common Feature of Melanoma

Journal of Investigative Dermatology
2014 | Journal article
DOI: 10.1038/jid.2013.264
WOSUID:

WOS:000328594000022
Contributors: Brooks, Kelly; Chia, Kee Ming; Spoerri, Loredana; Mukhopadhyay, Pamela; Wigan, Matthew; Stark, Mitchell; Pavey, Sandra; Gabrielli, Brian
Source: Self-asserted source
Mitchell Stark via ResearcherID
grade
Preferred source (of 2)‎

miRNAs: back seat drivers no more

Pigment Cell & Melanoma Research
2014 | Journal article
DOI: 10.1111/pcmr.12247
WOSUID:

WOS:000337619700005
Contributors: Stark, Mitchell S.
Source: Self-asserted source
Mitchell Stark via ResearcherID
grade
Preferred source (of 2)‎

Most common 'sporadic' cancers have a significant germline genetic component

Human Molecular Genetics
2014 | Journal article
DOI: 10.1093/hmg/ddu312
WOSUID:

WOS:000344671900023
Contributors: Lu, Yi; Ek, Weronica E.; Whiteman, David; Vaughan, Thomas L.; Spurdle, Amanda B.; Easton, Douglas F.; Pharoah, Paul D.; Thompson, Deborah J.; Dunning, Alison M.; Hayward, Nicholas K. et al.
Source: Self-asserted source
Mitchell Stark via ResearcherID

POT1 loss-of-function variants predispose to familial melanoma

Nature Genetics
2014 | Journal article
DOI: 10.1038/ng.2947
WOSUID:

WOS:000335422900015
Contributors: Robles-Espinoza, Carla Daniela; Harland, Mark; Ramsay, Andrew J.; Aoude, Lauren G.; Quesada, Victor; Ding, Zhihao; Pooley, Karen A.; Pritchard, Antonia L.; Tiffen, Jessamy C.; Petljak, Mia et al.
Source: Self-asserted source
Mitchell Stark via ResearcherID
grade
Preferred source (of 2)‎

Melanomas of unknown primary have a mutation profile consistent with cutaneous sun-exposed melanoma

Pigment Cell & Melanoma Research
2013 | Journal article
DOI: 10.1111/pcmr.12153
WOSUID:

WOS:000326032800015
Contributors: Dutton-Regester, Ken; Kakavand, Hojabr; Aoude, Lauren G.; Stark, Mitchell S.; Gartside, Michael G.; Johansson, Peter; O'Connor, Linda; Lanagan, Cathy; Tembe, Varsha; Pupo, Gulietta M. et al.
Source: Self-asserted source
Mitchell Stark via ResearcherID
grade
Preferred source (of 2)‎
Items per page:
Page 1 of 2
How many people are using ORCID?